iPSC Modeling of Presenilin1 Mutation in Alzheimer’s Disease with Cerebellar Ataxia

다국어 초록 (Multilingual Abstract)

Disease modeling of Alzheimer’s disease (AD) has been hampered by the lack of suitable cellular models while animal models are mainly based on the overexpression of AD-related genes which often results in an overemphasis of certain pathways and is also confounded by aging. In this study, we therefore developed and used induced pluripotent stem cell (iPSC) lines from a middle-aged AD patient with a known presenilin 1 (PSEN1) mutation (Glu120Lys; PS1-E120K) and as a control, an elderly normal subject. Using this approach, we demonstrated that the extracellular accumulation of Aβ was dramatically increased in PS1-E120K iPSC-derived neurons compared with the control iPSC line. PS1-E120K iPSC-derived neurons also exhibited high levels of phosphorylated tau, as well as mitochondrial abnormalities and defective autophagy. Given that the effect of aging is lost with iPSC generation, these abnormal cellular features are therefore indicative of PSEN1-associated AD pathogenesis rather than primary changes associated with aging. Taken together, this iPSC-based approach of AD modeling can now be used to better understand AD pathogenesis as well as a tool for drug discovery.

참고문헌 (Reference)

1 Verkkoniemi A, "Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype" 60 : 483-492, 2001

2 Trojanowski JQ, "The role of tau in Alzheimer’s disease" 86 : 615-627, 2002

3 McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 263-269, 2011

4 Spillantini MG, "Tau pathology and neurodegeneration" 12 : 609-622, 2013

5 Chesser AS, "Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease" 4 : 122-, 2013

6 Neely KM, "Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase-independent manner" 31 : 2781-2791, 2011

7 Dubois B, "Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria" 12 : 292-323, 2016

8 Koivunen J, "PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer’s disease" 131 : 1845-1853, 2008

9 Ochalek A, "Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation" 9 : 90-, 2017

10 Kondo T, "Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness" 12 : 487-496, 2013

11 Youle RJ, "Mitochondrial fission, fusion, and stress" 337 : 1062-1065, 2012

12 Holtzman DM, "Mapping the road forward in Alzheimer’s disease" 3 : 114ps48-, 2011

13 Zempel H, "Lost after translation: missorting of Tau protein and consequences for Alzheimer disease" 37 : 721-732, 2014

14 Itoh M, "Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene" 16 : 611-613, 2016

15 Manczak M, "Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer’s disease: implications for neuronal damage" 20 : 2495-2509, 2011

16 Wang X, "Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease" 29 : 9090-9103, 2009

17 Christensen KJ, "Health screening and random recruitment for cognitive aging research" 7 : 204-208, 1992

18 Burté F, "Disturbed mitochondrial dynamics and neurodegenerative disorders" 11 : 11-24, 2015

19 Mertens J, "Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects" 17 : 705-718, 2015

20 Rossi M, "Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux" 122 : 3330-3339, 2009

21 Nixon RA, "Autophagy failure in Alzheimer’s disease--locating the primary defect" 43 : 38-45, 2011

22 Nixon RA, "Autophagy and neuronal cell death in neurological disorders" 4 : a008839-, 2012

23 Götz J, "Animal models of Alzheimer’s disease and frontotemporal dementia" 9 : 532-544, 2008

24 LaFerla FM, "Animal models of Alzheimer disease" 2 : a006320-, 2012

25 Klunk WE, "Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees" 27 : 6174-6184, 2007

26 Brooks WS, "Alzheimer’s disease with spastic paraparesis and ‘cotton wool’plaques: two pedigrees with PS-1 exon 9 deletions" 126 : 783-791, 2003

27 Manczak M, "Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer’s disease" 21 : 5131-5146, 2012

28 Manczak M, "Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer’s disease neurons: implications for mitochondrial dysfunction and neuronal damage" 21 : 2538-2547, 2012

29 Choi SH, "A three-dimensional human neural cell culture model of Alzheimer’s disease" 515 : 274-278, 2014